# Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/trastuzumab-after-adjuvant-chemotherapy-in-her2-positive-breast-cancer/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Martine Piccart,Marion Procter,Brian Leyland‐Jones,Aron Goldhirsch,Michael Untch,Ian Smith,Luca Gianni,José Baselga,Richard H. Bell,Christian Jackisch,David Cameron,Mitch Dowsett,Carlos H. Barrios,Günther Steger,Chiun‐Sheng Huang,Michael Andersson,Moshe Inbar,Mikhail Lichinitser,István Láng,Ulrike Nitz,Hiroji Iwata,Christoph Thomssen,Caroline Lohrisch,Thomas Suter,Josef Rüschoff,Tamás Sütö,Victoria Greatorex,Carol Ward,Carolyn Straehle,Eleanor McFadden,Mirko Dolci,Richard D. Gelber |
| Citations | 5,111 |
| DOI | 10.1056/nejmoa052306 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://www.nejm.org/doi/pdf/10.1056/NEJMoa052306?articleTools=true |
| OpenAlex ID | https://openalex.org/W2149908785 |
| PMID | 16236737 |
| Type | article |
| Year | 2005 |

## Paper authors

- [Caroline Lohrisch](https://scholariq.org/researchers/caroline-lohrisch/)

## Paper journal

- [New England Journal of Medicine](https://scholariq.org/journals/new-england-journal-of-medicine/)

## Paper primary topic

- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

## Paper topics

- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.